Trial Profile
Administration of CIGB500 in healthy volunteers. Phase I study on scaling up dosages.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Oct 2020
Price :
$35
*
At a glance
- Drugs CIGB 500 (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions
- 31 Jul 2013 Status changed from active, no longer recruiting to completed as reported by Cuban Clinical Trial Registry.
- 30 Aug 2011 New trial record